| Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy A Alqahtani, K Choucair, M Ashraf, DM Hammouda, A Alloghbi, T Khan, ... Future science OA 5 (3), FSO372, 2019 | 274 | 2019 |
| Hepatocellular carcinoma: molecular mechanisms and targeted therapies A Alqahtani, Z Khan, A Alloghbi, T S. Said Ahmed, M Ashraf, ... Medicina 55 (9), 526, 2019 | 238 | 2019 |
| Gastrointestinal stromal tumor: a review of current and emerging therapies B Al-Share, A Alloghbi, MN Al Hallak, H Uddin, A Azmi, RM Mohammad, ... Cancer and Metastasis Reviews 40, 625-641, 2021 | 55 | 2021 |
| Trastuzumab deruxtecan-induced interstitial lung disease/pneumonitis in ERBB2-positive advanced solid malignancies: a systematic review Z Abuhelwa, A Alloghbi, A Alqahtani, M Nagasaka Drugs 82 (9), 979-987, 2022 | 54 | 2022 |
| A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC) Z Abuhelwa, A Alloghbi, M Nagasaka Cancer Treatment Reviews 106, 102393, 2022 | 36 | 2022 |
| PIK3CA gene aberrancy and role in targeted therapy of solid malignancies O Willis, K Choucair, A Alloghbi, L Stanbery, R Mowat, ... Cancer gene therapy 27 (9), 634-644, 2020 | 36 | 2020 |
| Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy. Future Sci OA. 2019; 5 (3): FSO372 A Alqahtani, K Choucair, M Ashraf, DM Hammouda, A Alloghbi, T Khan Epub 2019/03/25. https://doi. org/10.4155/fsoa-2018-0115 PMID: 30906568, 0 | 8 | |
| Prognostic utility of preoperative and postoperative KRAS-mutated circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: a systematic review and meta-analysis A Alqahtani, A Alloghbi, P Coffin, C Yin, R Mukherji, BA Weinberg Surgical Oncology, 102007, 2023 | 4 | 2023 |
| Prognostic utility of preoperative and postoperative circulating tumor DNA (ctDNA) in resected pancreatic ductal adenocarcinoma: A systematic review and meta-analysis. A Alqahtani, A Alloghbi, C Yin, R Mukherji, BA Weinberg Journal of Clinical Oncology 40 (4_suppl), 595-595, 2022 | 3 | 2022 |
| Anti‐PD‐1 therapy using cemiplimab for advanced cutaneous squamous cell carcinoma in HIV patient: A case report A Alloghbi, J Ninia, B Alshare, J Hotaling, S Raza, A Sukari Clinical Case Reports 9 (12), e05228, 2021 | 3 | 2021 |
| A case of a false-positive urine pregnancy test and delayed diagnosis of obstructive pyelonephritis R Mital, M Forster, A Alloghbi, A Kayyali The American Journal of Case Reports 21, e920440-1, 2020 | 3 | 2020 |
| Bromodomain and extra-terminal motif inhibitors: a review of preclinical and clinical advances in cancer therapy. Future Sci OA. 2019; 5: FSO372 A Alqahtani, K Choucair, M Ashraf, DM Hammouda, A Alloghbi, T Khan, ... | 2 | |
| Associations between micro-geographic social vulnerability and disparities in cancer incidence. I Aijazuddin, A Alloghbi, A Sukari Journal of Clinical Oncology 41 (16_suppl), e18523-e18523, 2023 | 1 | 2023 |
| A Review of Endocrine Therapy in Early-stage Breast Cancer: The Journey From Crudeness to Precision J Elayoubi, J Chi, AA Mahmoud, A Alloghbi, H Assad, M Shekhar, ... American Journal of Clinical Oncology 46 (5), 225-230, 2023 | 1 | 2023 |
| NTRK3 mutation in secretory carcinoma of the parotid gland: A Case report F AlKaabba, A Alloghbi, Y Deajim, MW Sukkari, MYA Khan, A Sukari Clinical Case Reports 10 (9), e6243, 2022 | 1 | 2022 |
| Romidepsin Treatment in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review and Meta-Analysis W Abdulsattar, A Beran, A Alqahtani, Z Abuhelwa, M Mhanna, A Alloghbi, ... American Journal of Therapeutics 29 (5), e589-e592, 2022 | 1 | 2022 |
| Outcomes with novel combinations in nonclear cell renal cell carcinoma (nccRCC): ORACLE study. D Kilari, A Szabo, P Ghatalia, TL Rose, H Dong, N Weise, TZ Zhuang, ... Journal of Clinical Oncology 40 (16_suppl), 4545-4545, 2022 | 1 | 2022 |
| Hepatic arterial infusion chemotherapy versus trans-arterial chemoembolization in unresectable hepatocellular carcinoma: A systematic review and meta-analysis. A Beran, Z Abuhelwa, W Abdulsattar, A Alloghbi, A Alqahtani, ... Journal of Clinical Oncology 40 (16_suppl), e16141-e16141, 2022 | 1 | 2022 |
| Oncology Early-Phase Clinical Trials in the Middle East and North Africa: A Review of the Current Status, Challenges, Opportunities, and Future Directions H Alotaibi, AM Anis, A Alloghbi, K Alshammari Journal of Immunotherapy and Precision Oncology 7 (3), 178-189, 2024 | | 2024 |
| National and state models for relationships between social vulnerability and mammography rates. I Aijazuddin, A Alloghbi, A Sukari Journal of Clinical Oncology 42 (16_suppl), 1573-1573, 2024 | | 2024 |
Khalil Choucair, MD, MSc.Karmanos Cancer Institute在 karmanos.org 的电子邮件经过验证
